Estimates Revisions NovoCure Limited Deutsche Boerse AG
Stocks
038
JE00BYSS4X48
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.58 EUR | -1.70% |
|
-12.47% | +21.40% |
| 06-30 | NovoCure Says Optune Pax Receives CE Mark for Locally Advanced Pancreatic Cancer Treatment | MT |
| 06-29 | NovoCure Limited(NasdaqGS:NVCR) added to Russell 2000 Value Benchmark | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- NVCR Stock
- 038 Stock
- Consensus NovoCure Limited
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
